|
|
Prognostic value of metabolic parameters and clinical impact of 18F-fluorocholine PET/CT in biochemical recurrent prostate cancer
Mathilde Colombié
,
Loïc Campion
,
C Bailly
,
Daniela Rusu
,
T Rousseau
,
et al.
Journal articles
inserm-01820167v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Quantitative evaluation of Therapeutic response by FDG-PET–CT in Metastatic Breast Cancer
Dorothée Goulon
,
Hatem Necib
,
Brice Henaff
,
Caroline Rousseau
,
Thomas Carlier
,
et al.
Journal articles
inserm-01414260v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.
Pierre-Yves Salaun
,
Loïc Campion
,
Catherine Ansquer
,
Eric Frampas
,
Cédric Mathieu
,
et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 (8), pp.1501-1510
Journal articles
hal-01111285v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
Pierre-Yves Salaun
,
Loïc Campion
,
Claire Bournaud
,
Alain Faivre-Chauvet
,
Jean-Philippe Vuillez
,
et al.
Journal articles
hal-00932253v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bone metastasis of a breast cancer detected by 3'-deoxy-3'-18F-fluorothymidine PET/CT
Alexandre Cochet
,
Alina Berriolo-Riedinger
,
Sylvie Girault
,
Caroline Rousseau
,
François Brunotte
,
et al.
Nuclear Medicine / Nuklearmedizin, 2009, 48 (5), pp.N45-N46
Journal articles
hal-00821306v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients.
Caroline Bodet-Milin
,
Ludovic Ferrer
,
Aurore Rauscher
,
Damien Masson
,
Latifa Rbah-Vidal
,
et al.
Journal articles
hal-01258870v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The predictive value of treatment response using FDG-PET performed at day 21 of chemo-radiotherapy in patients with oesophageal Squamous cell carcinoma. A prospective, multicentre study (RTEP3).
Odré Palie
,
Pierre Michel
,
Jean François Menard
,
Caroline Rousseau
,
Emmanuel Rio
,
et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 (9), pp.1345-55
Journal articles
hal-00936711v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prospects for Enhancing Efficacy of Radioimmunotherapy
Clément Bailly
,
Caroline Bodet-Milin
,
François Guérard
,
Caroline Rousseau
,
Michel Chérel
,
et al.
Book sections
inserm-02315459v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|